Medicine & Health

A new study led by WashU Medicine researchers including Jeffrey I. Gordon, MD, suggests that an intestinal disorder linked to malnutrition and stunted growth may be transmitted from one generation to the next via the small intestine’s microbiome.

Nathan Jacobs, a computer scientist at WashU McKelvey Engineering, and collaborators plan to develop a geospatial artificial intelligence tool to find early signs of instability in crop production.

Aaron Norris, MD, PhD, at WashU Medicine, has received a five-year $3.5 million NIH grant to study brain cells that regulate how the body burns calories and could lead to new ways to promote weight loss.

WashU Medicine serves as the official medical provider — and more — at the Greater St. Louis Marathon.

WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide — even temporarily — elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.

WashU’s Good Nurtured spring wellness challenge gets underway soon. It takes a holistic approach to well-being and encourages showing and receiving kindness, civility and graciousness. Register today.

WashU Medicine researchers have shown in a new study that GLP-1 medications, typically used for diabetes and weight loss, may be effective at treating and preventing substance use disorders, from alcohol to cigarettes to opioids.

Researchers at WashU Medicine have found a strong correlation between obesity in one or both parents during pregnancy and their child’s risk of developing a common liver disorder.

Leaders from seven countries explored the WashU FARM initiative’s public health-driven research and global partnerships advancing sustainable, equitable food systems.

A study by researchers at WashU Medicine reveals how the body reprograms stable fat cells to eliminate stubborn fat reserves.